NWBO’s October news connects: NHSBT production support, US manufacturing restart plans, QA expertise and product tracking. My bullish take: a coordinated build-out for DCVax-L at scale while MHRA reviews. Glioblastoma patients are why this matters. $NWBO
So terrible that even after help from @TheTimMcGraw, a real warrior Michael Hugo has not defeated Glioblastoma.
I hope that happens with @NorthwestBio DCVax-L.
@FDA@realDonaldTrump@DrOz@SecKennedy approve DCVax now!
https://t.co/rpMltrjHjD
https://t.co/LDaJnAd6cs
$nwbo
The momentum is palpable. I feel we are close to the end of a bumpy road and are about to hit the jet stream.
#DCVaxForBraelyn#FDA
https://t.co/l3Wj5J8hb4
🇺🇸❤️ WE MET PRESIDENT TRUMP TONIGHT! ❤️🇺🇸
What an extraordinary evening for our family!
Tonight, Braelyn, Ben, and I had the incredible opportunity to meet President Trump at the rally in Pendleton, South Carolina!
We had only about 20–30 seconds with him, and I knew I needed to make every second count.
I introduced him to Braelyn and thanked him for telling Dr. Oz about her brain cancer story.
I explained that Braelyn had been diagnosed with glioblastoma, the deadliest type of brain tumor, but that today she is CANCER-FREE after receiving DCVax-L, a personalized cancer vaccine developed right here in America!
Yet we must travel all the way to England for her ongoing treatments because we cannot access it here in the United States.
Then something pretty cool happened!
President Trump turned to one of his staffers and instructed them to get me in touch with Dr. Oz!
I also expressed my hope that we could connect with Secretary Kennedy.
As our brief time together came to an end, I made one final appeal:
“Please help bring this American-made treatment back home to America.”
President Trump was incredibly gracious to our family and very kind to Braelyn. We are so grateful for the opportunity to speak with him!
Earlier in the evening, I was also able to give a member of his staff a detailed packet about Braelyn’s journey, DCVax-L, and the obstacles American patients face in accessing promising investigational treatments.
Now we are praying that the connection with Dr. Oz comes through!
Three years ago, Braelyn was given just months to live. Today, she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE!
Tonight, we had the opportunity to bring her story directly to the President of the United States. ❤️
My prayer is that this opens the door to a much bigger conversation—one that could change the future for countless American cancer patients.
📸 We were not permitted to bring our phones into the private meeting with President Trump, so we couldn’t take our own pictures with him. His staff took an official photograph of us together, which we’re told will be emailed to us. I can’t wait to share it! In the meantime, here are some pictures from our unforgettable evening.
Thank you to EVERYONE who helped make tonight possible and to all of you who continue to share Braelyn’s story. You helped us get this far, and we’re not stopping now! ❤️🙏
@realDonaldTrump@DrOzCMS@WhiteHouse
#DCVaxForBraelyn #DCVax
I made some significant changes to my discount cash flow analysis of $NWBO and added those to LinkedIn.
https://t.co/UDfAp9MUKM
The actual spreadsheet is included.
My price target upon MHRA approval has been lowered to $67.30 per share.
I only include oncology in the model with Keytruda as baseline.
Thanks @andrewcaravello for providing supporting evidence to the article.
$nwbo
This is fantastic news, I look forward to the continued PR and updates on the future of personalized cancer vaccines.
My own mother had life-long impacts of stage IV breast cancer and the radiation and Chemo.
Glad to see the future is bright.
https://t.co/UJCyL0HNVO
Three weeks later, I still have trouble believing I was able to write these words:
NO EVIDENCE OF DISEASE. 🙏❤️
I’m sharing this again because Braelyn’s story is about so much more than one incredible MRI.
It’s about what can happen when someone refuses to accept that there are no more options.
Please read her story. And please share it. There are other families who need to know that “there’s nothing more we can do” does not always mean there is nothing more that can be done.
$NWBO
#DCvaxForBraelyn
You know I never ask others to give unless I first give…when I just gave again to help this girl get treatment for brain cancer…and guess what? She is responding to the treatment!!! That is great news - if you can, please also give whatever you can https://t.co/nZe8nTu0pD — if all 1.2 million follows of mine gave, we could reach the goal in an hour!
$NWBO finally getting some attention. Glad to see it.
I’ve been an investor for six years, it’s been exhausting, but I believe in the technology. Going to the moon or the crater with it.
$NWBO 🧬
⚖️ | Northwest Biotherapeutics, Inc. v. Canaccord Genuity LLC et al. | S.D.N.Y., No. 1:22-cv-10185 | Filed September 14, 2026 | Docs. 342–344
⚠️Not Legal Advice - A quick summary-
These filings respond to Citadel’s and Virtu’s requests to seal parts of sworn statements describing their automated trading systems (Docs. 333 and 336). They concern what the public can see, not a ruling on whether improper trading occurred. 📄🔍
🔒 Doc. 342: NWBO asks to file its opposition temporarily under seal so it does not reveal material while the judge considers the defendants’ requests. NWBO says it ultimately believes the material should be public.
⚖️ Doc. 343: NWBO opposes the sealing requests. It argues that Citadel and Virtu have not shown specifically how disclosure would harm them, and says some information they want hidden resembles information other defendants left public. NWBO asks Judge Stein to deny the motions. ➡️ One notable line from the filing: “over 100 members of the public attended the recent hearing regarding this subject.” 👥
📁 Doc. 344: The docket lists a sealed copy of NWBO’s opposition, tied to its temporary-seal request in Doc. 342. The public version is Doc. 343.
What might come next? Judge Stein may decide how much of the statements and this opposition remain sealed. A decision about public access would not, by itself, decide the trading allegations.
⚠️Not legal advice.
🧬❤️ The NWBO story reaches far beyond the courtroom. Braelyn’s family just heard the words they had waited nearly three years to hear: “NO EVIDENCE OF DISEASE.” Behind every debate about trading and every docket entry are real patients, families, and scientists working to give people more time. That’s why this case matters so deeply. 🙏 @kshaughnessy2
$NWBO
If I'm not mistaken, Braelyn received her first dose of DCVax-L on July 22. Within about a month, after three doses, an intense anti-tumor immune response already wiped out the remaining unresected 10% of tumor tissue. The vaccine was made from her own tumor tissue, so it was a genetic match and that is why it cannot be toxic. More importantly, the DCs presenting hundreds of tumor-associated peptides on MHC Class II engage CD4 T-cells, which are essential for building immune memory. Once that memory is established, the risk of recurrence can drop dramatically. It's hard to imagine a better treatment than this — which may be exactly why approval has taken so long!
🙏💕🙏 BRAELYN'S NO EVIDENCE OF DISEASE
This is the miracles that Market Makers are trying to destroy for profit.
NWBO paired with amazing doctors like like Dr. Liau are saving lives 🙏💕
@ThomasOwenMcCa1
You are an exceptional person 🙏
🙏🙏 For Braelyn's continued recovery and a long healthy life.